Загрузка...
Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption
CONTEXT: The effect of sotagliflozin (a dual sodium–glucose cotransporter [SGLT] 2 and SGLT1 inhibitor) on intestinal glucose absorption has not been investigated in humans. OBJECTIVE: To measure rate of appearance of oral glucose (R(a)O) using a dual glucose tracer method following standardized mix...
Сохранить в:
| Опубликовано в: : | J Clin Endocrinol Metab |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7067537/ https://ncbi.nlm.nih.gov/pubmed/31837264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgz258 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|